Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2005-02-28
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains.
2. Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer.
3. Some aspect of baseline patient characteristic will be predictive of cancer-related outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
NCT00923884
Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
NCT00483015
Cancer of the Lung And SeneScencE - Prospective Cohort 1
NCT06923618
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study
NCT06909981
Lung Cancer Mutation Consortium Protocol
NCT01014286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to participate in activities of daily living assessment
* Can use a cane or walker
* Willing to complete a balance performance assessment, if able.
Exclusion Criteria
* Has a previous history of brain cancer
* Significant neurological disease other than AD that might affect cognitive function, such as stroke, Parkinson's disease, multiple sclerosis, or serious traumatic brain injury.
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanjay Asthana, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2004-0341
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.